TechCrunch

MARCH 17, 2023

Suggestions like “listen to your customers” and “make data-driven decisions” are so general, they’re hard to implement. “While excessive or unhelpful customer data can clog content pipelines, the right information can power hyper-personalization at scale,” he writes.

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

AUGUST 25, 2021

In an increasingly hot biotech market, protecting IP is key. If you expect a return on investment, you can’t spend that kind of cash improving a niche crop for an outlier market. The Avalo model clears up the data and selects only the most promising ones. Image Credits: Avalo.

Artificial Inteligence 246

Artificial Inteligence Machine Learning Biotech Study 246

TechCrunch

JULY 16, 2022

Welcome to The TechCrunch Exchange, a weekly startups-and-markets newsletter. That’s exactly what’s happening in health tech right now, as the sector benefits not only from the rise of open data, but also from the democratization of data analytics and privacy-preserving synthetic data. Sign up here.

Artificial Inteligence 236

Artificial Inteligence Data Healthcare Trends 236

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. “Right now the market is in ‘biotechnology winter’ where many companies are running out of cash and are dying.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

Perficient

MAY 21, 2024

An inefficient system wastes time and resources, can diminish morale, and ultimately hinders efforts to bring life-saving drugs to market. We Shared Our Client’s Vision For a Smarter, Faster Way of Working Our client needed a solution that could integrate disparate data sources seamlessly into a robust and intuitive environment.

Pharmaceuticals 52

Pharmaceuticals Artificial Inteligence Data Systems Review 52

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Let’s see if April can continue the trend of a growing amount of large raises. The company uses machine-generated content and AI to push marketing initiatives.

Biotech 103

Biotech Artificial Intelligence Artificial Inteligence Energy 103

TechCrunch

SEPTEMBER 8, 2022

Data needs to be stored somewhere. However, data storage costs keep growing, and the data people keep producing and consuming can’t keep up with the available storage. According to Internet Data Center (IDC) , global data is projected to increase to 175 zettabytes in 2025, up from 33 zettabytes in 2018.

Storage 206

Storage Artificial Inteligence Data Chemicals 206

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 91

Lambda Biotech Artificial Intelligence Artificial Inteligence 91

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. This could push the price lower, but for now a 90% reduction is more than enough to go to market with.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. Data security startup Cyera raised a $300 million Series C led by Coatue at a $1.4 Let’s take a look. billion valuation.

Biotech 109

Biotech Generative AI Blockchain Energy 109

TechCrunch

JANUARY 10, 2023

German-based biotech company BioNTech — one of the big manufacturers of COVID-19 vaccines, among other things — is set to acquire InstaDeep , a Tunis-born and U.K.-based It gives brands a way to conduct market research and collect first-party data, which is important as marketers prepare for a post-cookie world.

Trends 219

Trends Marketing ChatGPT Biotech 219

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. That’s still a lot of cash, but clearly round size trended down.

Biotech 102

Biotech Generative AI Artificial Intelligence Artificial Inteligence 102

TechCrunch

SEPTEMBER 28, 2021

Genomic data is considered to be the key to unlocking so-called “precision medicine” Some estimates suggest that by 2025, 500 million human genomes will have been sequenced, but only a fraction of it is being utilized for drug discovery and precision medicine. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

TechCrunch

MAY 26, 2021

Digital drug discovery in general means large-scale analysis of biological data like genes, gene expression, protein structures, binding sites, things like that. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

MARCH 22, 2024

Mirador Therapeutics , $400M, biotech: More big biotech raises this week. With breakthroughs in genetics and machine learning, the company is focused on precision medicine for chronic inflammation and fibrotic disease. Clasp Therapeutics , $150M, biotech: Clasp Therapeutics is the next biotech to raise huge.

Biotech 85

Biotech Blockchain Healthcare Fintech 85

Crunchbase News

APRIL 4, 2024

The first quarter of 2024 was the second-lowest on record for global startup funding since the beginning of 2018, according to an analysis of Crunchbase data. Global venture funding reached $66 billion in the first quarter, up 6% quarter over quarter but down 20% year over year, Crunchbase data shows.

Artificial Inteligence 123

Artificial Inteligence Healthcare Biotech Report 123

TechCrunch

JANUARY 25, 2022

Meanwhile, the company is developing machine learning algorithms with the ability to pick out subpar cells. . In an increasingly hot biotech market, protecting IP is key. She’ll plan to expand the machine learning capacity of the platform — a key part of making Cellino’s platform truly autonomous.

Biotech 246

Biotech Machine Learning Artificial Inteligence Study 246

Crunchbase News

FEBRUARY 15, 2024

The venture market was down 38% last year as investors continued to reel back their funding with money becoming more expensive and liquidity options drying up. With its cash-intensive research and long product-to-market lead time, it usually is not attractive to investors in a down market where cash is king.

Biotech 92

Biotech Artificial Intelligence Artificial Inteligence Energy 92

TechCrunch

JULY 19, 2022

Persephone Biosciences is a biotech startup that — with the help of $15 million and a lot of poop — is building a library of the human microbiome and assembling a best-of list of helpful life forms that could do everything from easing digestion to fighting serious disease. Persephone’s all-in-one “poop kit.”

Biotech 240

Biotech Study Machine Learning Artificial Inteligence 240

TechCrunch

APRIL 30, 2021

We are at a similar inflection point in healthcare, with the recent movement toward data transparency birthing a new generation of innovation and startups. Anonymized data is much more freely available, while personal data is being locked even tighter (as it should be) due to regulations like GDPR, CCPA and their equivalents around the world.

Healthcare 184

Healthcare Data Biotech Systems Review 184

Crunchbase News

FEBRUARY 27, 2024

based on 2023 data from Crunchbase and its Diversity Spotlight feature. startups last year totaled only $705 million — marking the first time since 2016 that the figure failed to even reach $1 billion, Crunchbase data shows. fell 37% last year , funding to Black-founded startups dropped a staggering 71%, according to Crunchbase data.

Marketing 133

Marketing Biotech Report Data 133

Crunchbase News

FEBRUARY 7, 2024

billion, per Crunchbase data. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificial intelligence-related tech from virtual assistants to no-code tools to build AI apps.

Energy 76

Energy Biotech Artificial Intelligence Artificial Inteligence 76

Crunchbase News

APRIL 8, 2024

billion in Q1 of 2024, per Crunchbase data. Per Crunchbase data, investors participated in 2,435 known rounds at all stages in the course of the quarter. On the exit front, meanwhile, Q1 brought some renewed excitement to the moribund IPO market with well-received debuts of Reddit and Astera Labs. Round counts fell too.

Biotech 117

Biotech Artificial Intelligence Artificial Inteligence Quality Assurance 117

Crunchbase News

MAY 7, 2024

Global venture capital funding reached just over $22 billion in April 2024 — flat month over month and up a few percentage points year over year — Crunchbase data shows. billion, representing about 49% of funding last month, Crunchbase data shows. Top sectors Biotech and healthcare was the leading sector by funding amount in April.

Biotech 116

Biotech Generative AI Report Healthcare 116

Crunchbase News

JANUARY 8, 2024

In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. billion into startups and growth-stage companies at Series C and beyond, per Crunchbase data. For the fourth quarter, the largest early-stage rounds hailed from the biotech space.

Biotech 94

Biotech Generative AI Insurance Artificial Intelligence 94

TechCrunch

NOVEMBER 18, 2021

Therapeutic proteins, particularly monoclonal antibodies, are making up a bigger and bigger share of the drug market. Generate Biomedicines is focused on all protein modalities, but they have initially focused on developing antibodies, which Nally says make up about 60% of the protein-based biotherapeutics market. .

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

TechCrunch

JANUARY 25, 2023

The biotech industry is experiencing a rush of AI-powered tools for many aspects of the complex drug discovery process. The result is a severe lack of knowledge and data on RNA structures. ” This absolutely bare-bones model wiped the floor with others, as disclosed in a front-page article published in Science in 2021. .

Pharmaceuticals 202

Pharmaceuticals Biotech Machine Learning Artificial Inteligence 202

TechCrunch

OCTOBER 5, 2021

Andiamo uses machine learning, 3D simulation and 3D printing to create custome braces for children with cerebral palsy, bringing down the cost and improving outcomes for clinicians, patients and families alike. Frontrunner combines sports betting with the flexibility of the stock market. departments.

Company 208

Company Meeting Sport 3D 208

Crunchbase News

MAY 21, 2024

Still, considering the overall VC market in 2024, the large number of megadeals seem out of place. Instead it’s actually biotech and healthcare lapping the field when it comes to megadeals, with such startups rising a whopping 38 so far this year. Where is the money going? billion round led by Coatue earlier this month.

Biotech 96

Biotech Games Healthcare Cloud 96

Crunchbase News

FEBRUARY 8, 2024

Last week AI private market investors likely rejoiced when it was reported data center startup Astera Labs was preparing for a potential March initial public offering. When Astera raised its massive round in 2022, the market for funding for U.S.-based Also, not every chip designer startup is focused on the AI market.

Artificial Intelligence 83

Artificial Intelligence Artificial Inteligence Software Review Systems Review 83

Crunchbase News

FEBRUARY 23, 2024

Recogni , $102M, artificial intelligence: Although most startup chipmakers have not seen much love from investors so far this year , Recogni seems to have bucked that trend. While the company has its roots in designing chips that help autonomous vehicles detect objects, it is now also exploring the AI market.

Artificial Intelligence 92

Artificial Intelligence Artificial Inteligence Energy Backup 92

TechCrunch

SEPTEMBER 30, 2021

Conventional electronic media like flash drives and hard drives require energy consumption to process a vast amount of high-density data and information overload and are vulnerable to security issues due to the limited space for storage. There is also an expensive cost issue when it comes to transmitting the stored data.

Storage 238

Storage Data Energy Chemicals 238

Crunchbase News

FEBRUARY 16, 2024

Here at Crunchbase News, we have our own future-telling tool: Seed-funding data. AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare. New York-based Jona wants to use artificial intelligence to uncover links between the microbiome and health.

Construction 110

Construction Artificial Intelligence Artificial Inteligence Generative AI 110

TechCrunch

APRIL 21, 2021

There are any number of seed rounds that cross our desks every day, a never-ending march of enterprise software, consumer apps, games, hardware, biotech and sometimes even a space startup. So when Affect’s $1 million seed round from AlleyCorp came to my attention, I wanted to learn a bit more. Let’s hope.

Biotech 187

Biotech Software Review Technical Review Machine Learning 187

Crunchbase News

FEBRUARY 9, 2024

there were a good number of other large deals as well. That included more than $200 million for a security company and lots of big biotech raises. Founded in 1991, the Fortnite creator has raised nearly $8 billion to date, according to Crunchbase data. Epic Games , $1.5B, gaming: Epic Games is not a stranger to this list.

Biotech 76

Biotech Games Healthcare Generative AI 76

Crunchbase News

DECEMBER 20, 2023

The startup already has unveiled a market-ready cognitive collaborative robot — or “cobot” as the company calls it — named MAiRA. market while offering a solution to the increasing shortage of skilled workers. A robot enhanced with AI that can work with humans and learn — both scary and interesting. Close more.

Biotech 106

Biotech Artificial Intelligence Artificial Inteligence Energy 106

Crunchbase News

APRIL 17, 2024

Lately, however, sequential rounds aren’t always getting bigger, a review of Crunchbase data suggests. Cancer-focused biotech Freenome , meanwhile, picked up $46 million less in its Series E compared to its Series D. billion in Series E and Series F rounds so far this year, per Crunchbase data. ↩

Biotech 88

Biotech Comparison Systems Review Survey 88